First of all, IQ tests aren't designed for high IQ, so there's a lot of noise there and this would mainly be noise, if he correctly reported the results, which he doesn't.
Second, there are some careful studies of high IQ (SMPY etc) by taking the well designed SAT test, which doesn't have a very high ceiling for adults and giving it to children below the age of 13. By giving the test to representative samples, they can well characterize the threshold for the top 3%. Using self-selected samples, they think that they can characterize up to 1/10,000. In any event, within the 3% they find increasing SAT score predicts increasing probability of accomplishments of all kinds, in direct contradiction of these claims.
Subscribe to RSS Feed
= f037147d6e6c911a85753b9abdedda8d)
This raises some interesting questions.
If the end result is fraud and bad medicine, whether you regulate more or less, is that a reason to regulate less so money isn't wasted on mandatory fraudulent studies?
Regulation raises the the barrier of entry to selling medicine. Does this reduce the amount of fraud because it's harder to to sell completely untested medicine and there's at least some quality control by the regulator? Or does it increase the amount of fraud because once a drug costs huge amounts of money to develop and approve, companies are less willing to take a loss if they discover the drug doesn't really work, and so lie more?
Don't regulate efficiency. Regulate consistency of formulation, at most.
There are plenty of actors interested in efficacy. Really, everyone else involved.